Literature DB >> 8037746

Differential regulation of constitutive and inducible nitric oxide production by inflammatory stimuli in murine endothelial cells.

R Walter1, A Schaffner, G Schoedon.   

Abstract

The murine vascular endothelial cell line send1 expresses both constitutive and inducible nitric oxide (NO) synthases. Interferon-gamma (IFN gamma) or endotoxin (LPS) alone inhibited constitutive NO production in a dose and time dependent manner. Addition of L-arginine had no influence on the decrease of NO production caused by IFN gamma or LPS. On the other hand, IFN gamma and LPS synergized in the induction of high output NO production. Successive incubations with IFN gamma and LPS in different sequences revealed IFN gamma as the time setting signal for the induction of NO synthesis. These results demonstrate that LPS and IFN gamma have a direct suppressive effect on constitutive NO synthase while at the same time they strongly activate inducible NO production. Thus inflammatory stimuli trigger murine vascular endothelial cells to switch from constitutive to inducible NO synthase activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037746     DOI: 10.1006/bbrc.1994.1949

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study.

Authors:  J de Boer; H Meurs; W Coers; M Koopal; A E Bottone; A C Visser; W Timens; J Zaagsma
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Local nitric oxide production in viral and autoimmune diseases of the central nervous system.

Authors:  D C Hooper; S T Ohnishi; R Kean; Y Numagami; B Dietzschold; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

3.  Endogenously produced nitric oxide inhibits endothelial cell growth as demonstrated using novel antisense cell lines.

Authors:  J E Cartwright; A P Johnstone; G S Whitley
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide.

Authors:  A Morikawa; N Koide; Y Kato; T Sugiyama; D Chakravortty; T Yoshida; T Yokochi
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

5.  Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.

Authors:  C Szabó; R Bryk; B Zingarelli; G J Southan; T C Gahman; V Bhat; A L Salzman; D J Wolff
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Regulation of staphylococcal enterotoxin B-elicited nitric oxide production by endothelial cells.

Authors:  R D LeClaire; W M Kell; R A Sadik; M B Downs; G W Parker
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

7.  Nitric oxide function in atherosclerosis.

Authors:  K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.